Track PHAT and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
PHAT - Phathom Pharmaceuticals Inc (PHAT) has a shares outstanding of 82.05M, up 12.5% over the past year.
Shares Outstanding
82.05M
Dilution %
+1439.04%
Annual Change
+12.52%
| Year | Shares | Change |
|---|---|---|
| 2026 | 82.05M | +12.52% |
| 2025 | 72.92M | +2.64% |
| 2024 | 71.05M | +38.52% |
| 2023 | 51.29M | +24.15% |
| 2022 | 41.31M | +9.41% |
| 2021 | 37.76M | +10.86% |
| 2020 | 34.06M | +4.90% |
| 2019 | 32.47M | +278.52% |
| 2018 | 8.58M | - |
| Quarter | Shares | Change |
|---|---|---|
| Q1 2026 | 82.05M | +12.52% |
| Q4 2025 | 72.92M | -0.65% |
| Q3 2025 | 73.40M | +1.28% |
| Q2 2025 | 72.47M | +0.69% |
| Q1 2025 | 71.97M | +1.30% |
| Q4 2024 | 71.05M | +9.93% |
| Q3 2024 | 64.63M | +10.37% |
| Q2 2024 | 58.56M | +0.32% |
| Q1 2024 | 58.37M | +13.81% |
| Q4 2023 | 51.29M | -9.67% |
| Q3 2023 | 56.78M | +17.08% |
| Q2 2023 | 48.50M | +14.51% |
| Q1 2023 | 42.35M | +2.53% |
| Q4 2022 | 41.31M | +6.42% |
| Q3 2022 | 38.82M | +1.43% |
| Q2 2022 | 38.27M | +0.62% |
| Q1 2022 | 38.04M | +0.74% |
| Q4 2021 | 37.76M | +1.23% |
| Q3 2021 | 37.30M | +1.81% |
| Q2 2021 | 36.64M | +0.93% |
| Q1 2021 | 36.30M | +6.57% |
| Q4 2020 | 34.06M | +2.08% |
| Q3 2020 | 33.37M | +1.12% |
| Q2 2020 | 33.00M | +1.62% |
| Q1 2020 | 32.47M | +0.00% |
| Q4 2019 | 32.47M | +41.85% |
| Q3 2019 | 22.89M | +166.84% |
| Q2 2019 | 8.58M | +0.00% |
| Q1 2019 | 8.58M | +0.00% |
| Q4 2018 | 8.58M | +0.00% |
| Q3 2018 | 8.58M | +60.90% |
| Q2 2018 | 5.33M | +0.00% |
| Q1 2018 | 5.33M | - |
Shares outstanding is the total number of a company's shares currently held by all its shareholders. A shrinking share count usually reflects buybacks that raise each remaining share's claim on earnings, while a rising count can signal dilution.